至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

RNAi-mediated knockdown of IKK1 in transgenic mice using a transgenic construct containing the human H1 promoter.

ScientificWorldJournal. 2014; 
Moreno-MaldonadoRodolfo,MurillasRodolfo,NavarroManuel,PageAngustias,Suarez-CabreraCristian,AlamedaJosefa P,BravoAna,CasanovaM Llanos,RamirezA
Products/Services Used Details Operation
Gene Synthesis … 5 . a. Using UH-IND-A and U6-IND-02-B primer to perform a PCR reaction on pRNA-U6.1/Neo (Genscript, Cat# SD1201) using pfu enzyme. Purify the PCR product … d. Cut the pRNA-U6.1/Neo/ siFLuc (Genscript, Cat #SD1501) with MluI and BamH I to get the vector fragments … Get A Quote

摘要

Inhibition of gene expression through siRNAs is a tool increasingly used for the study of gene function in model systems, including transgenic mice. To achieve perdurable effects, the stable expression of siRNAs by an integrated transgenic construct is necessary. For transgenic siRNA expression, promoters transcribed by either RNApol II or III (such as U6 or H1 promoters) can be used. Relatively large amounts of small RNAs synthesis are achieved when using RNApol III promoters, which can be advantageous in knockdown experiments. To study the feasibility of H1 promoter-driven RNAi-expressing constructs for protein knockdown in transgenic mice, we chose IKK1 as the target gene. Our results indicate that... More

关键词